Thaddeus L Miller1, Fernando A Wilson, Jenny W Pang, Suzanne Beavers, Sally Hoger, Sharon Sharnprapai, Melissa Pagaoa, Dolly J Katz, Stephen E Weis. 1. Thaddeus L. Miller is with the Department of Health Management and Policy, University of North Texas Health Science Center, Fort Worth. Stephen E. Weis is with the Department of Medicine, University of North Texas Health Science Center. Fernando A. Wilson is with the Department of Health Services Research & Administration, University of Nebraska Medical Center, Omaha. Jenny W. Pang is with the Department of Epidemiology, University of Washington School of Public Health, Seattle. Suzanne Beavers, Melissa Pagaoa, and Dolly J. Katz are with the Centers for Disease Control and Prevention, Atlanta, GA. Sally Hoger is with the Department of Medical Laboratory Sciences, Tarleton State University, Fort Worth, TX. Sharon Sharnprapai is with the Massachusetts Department of Public Health, Boston.
Abstract
OBJECTIVES: We compared mortality among tuberculosis (TB) survivors and a similar population. METHODS: We used local health authority records from 3 US sites to identify 3853 persons who completed adequate treatment of TB and 7282 individuals diagnosed with latent TB infection 1993 to 2002. We then retrospectively observed mortality after 6 to 16 years of observation. We ascertained vital status as of December 31, 2008, using the Centers for Disease Control and Prevention's National Death Index. We analyzed mortality rates, hazards, and associations using Cox regression. RESULTS: We traced 11 135 individuals over 119 772 person-years of observation. We found more all-cause deaths (20.7% vs 3.1%) among posttreatment TB patients than among the comparison group, an adjusted average excess of 7.6 deaths per 1000 person-years (8.8 vs 1.2; P < .001). Mortality among posttreatment TB patients varied with observable factors such as race, site of disease, HIV status, and birth country. CONCLUSIONS: Fully treated TB is still associated with substantial mortality risk. Cure as currently understood may be insufficient protection against TB-associated mortality in the years after treatment, and TB prevention may be a valuable opportunity to modify this risk.
OBJECTIVES: We compared mortality among tuberculosis (TB) survivors and a similar population. METHODS: We used local health authority records from 3 US sites to identify 3853 persons who completed adequate treatment of TB and 7282 individuals diagnosed with latent TB infection 1993 to 2002. We then retrospectively observed mortality after 6 to 16 years of observation. We ascertained vital status as of December 31, 2008, using the Centers for Disease Control and Prevention's National Death Index. We analyzed mortality rates, hazards, and associations using Cox regression. RESULTS: We traced 11 135 individuals over 119 772 person-years of observation. We found more all-cause deaths (20.7% vs 3.1%) among posttreatment TB patients than among the comparison group, an adjusted average excess of 7.6 deaths per 1000 person-years (8.8 vs 1.2; P < .001). Mortality among posttreatment TB patients varied with observable factors such as race, site of disease, HIV status, and birth country. CONCLUSIONS: Fully treated TB is still associated with substantial mortality risk. Cure as currently understood may be insufficient protection against TB-associated mortality in the years after treatment, and TB prevention may be a valuable opportunity to modify this risk.
Authors: Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh Journal: Am J Respir Crit Care Med Date: 2011-09-01 Impact factor: 21.405
Authors: Jotam G Pasipanodya; Scott Jn McNabb; Peter Hilsenrath; Sejong Bae; Kristine Lykens; Edgar Vecino; Guadalupe Munguia; Thaddeus L Miller; Gerry Drewyer; Stephen E Weis Journal: BMC Public Health Date: 2010-05-19 Impact factor: 3.295
Authors: M Fleshner; K N Olivier; P A Shaw; J Adjemian; S Strollo; R J Claypool; L Folio; A Zelazny; S M Holland; D R Prevots Journal: Int J Tuberc Lung Dis Date: 2016-05 Impact factor: 2.373
Authors: Suzanne F Beavers; Lisa Pascopella; Amy L Davidow; Joan M Mangan; Yael R Hirsch-Moverman; Jonathan E Golub; Henry M Blumberg; Risa M Webb; Rachel A Royce; Susan E Buskin; Michael K Leonard; Paul C Weinfurter; Robert W Belknap; Stephen E Hughes; Jon V Warkentin; Sharon F Welbel; Thaddeus L Miller; Saini R Kundipati; Michael Lauzardo; Pennan M Barry; Dolly J Katz; Denise O Garrett; Edward A Graviss; Jennifer M Flood Journal: Ann Am Thorac Soc Date: 2018-06
Authors: Mehdi Kazempour-Dizaji; Mohammad Varahram; Payam Tabarsi; Rahim Roozbahani; Ali Zare; Mohammad Ali Emamhadi; Majid Marjani; Atefe Abedini; Afshin Moniri; Mohammadreza Madani; Parvaneh Baghaei Shiva Journal: Tanaffos Date: 2022-01
Authors: Serena P Koenig; Ahra Kim; Bryan E Shepherd; Carina Cesar; Valdilea Veloso; Claudia P Cortes; Denis Padgett; Brenda Crabtree-Ramírez; Eduardo Gotuzzo; Catherine C McGowan; Timothy R Sterling; Jean W Pape Journal: Clin Infect Dis Date: 2020-06-24 Impact factor: 9.079
Authors: Yvetot Joseph; Zhiwen Yao; Akanksha Dua; Patrice Severe; Sean E Collins; Heejung Bang; Marc Antoine Jean-Juste; Oksana Ocheretina; Alexandra Apollon; Margaret L McNairy; Kathryn Dupnik; Etienne Cremieux; Anthony Byrne; Jean W Pape; Serena P Koenig Journal: J Int AIDS Soc Date: 2021-07 Impact factor: 5.396